9.42
price up icon0.96%   0.09
after-market 시간 외 거래: 9.50 0.08 +0.85%
loading

Immunome Inc 주식(IMNM)의 최신 뉴스

pulisher
03:55 AM

Victory Capital Management Inc. Boosts Holdings in Immunome, Inc. (NASDAQ:IMNM) - Defense World

03:55 AM
pulisher
Nov 18, 2024

Wedbush Has Bullish Outlook for Immunome FY2024 Earnings - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Leerink Partnrs Decreases Earnings Estimates for Immunome - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

FY2024 EPS Estimates for Immunome Lowered by Leerink Partnrs - Defense World

Nov 18, 2024
pulisher
Nov 16, 2024

Immunome Inc. Announces Third Quarter 2024 Financial Results and Pipeline Progress - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

Immunome Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Immunome (NASDAQ:IMNM) Stock Price Down 7% After Analyst Downgrade - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

T. Rowe Price Investment Management, Inc. Expands Stake in Immun - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Piper Sandler maintains overweight on IMNM with $21 target By Investing.com - Investing.com Canada

Nov 14, 2024
pulisher
Nov 14, 2024

Piper Sandler maintains overweight on IMNM with $21 target - Investing.com India

Nov 14, 2024
pulisher
Nov 14, 2024

Immunome Reports Third Quarter 2024 Financial Results and Provides Business Update - BioSpace

Nov 14, 2024
pulisher
Nov 14, 2024

Janus Henderson Group's Strategic Acquisition of Immunome Inc Sh - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Immunome (NASDAQ:IMNM) Shares Down 7% Following Analyst Downgrade - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Piper Sandler Cuts Immunome (NASDAQ:IMNM) Price Target to $21.00 - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Immunome price target lowered to $21 from $23 at Piper Sandler - TipRanks

Nov 14, 2024
pulisher
Nov 13, 2024

Immunome, Inc. Reports Q3 2024 Financial Results - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Immunome Inc (IMNM) Q3 2024 Earnings: Revenue Surpasses Estimates at $2.91M, GAAP EPS Misses at -$0.78 - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Immunome, Inc. (IMNM) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Nov 13, 2024
pulisher
Nov 13, 2024

Immunome, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

Immunome Reports $47.1M Q3 Loss, Advances Cancer Pipeline with Strong Cash Position | IMNM Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 13, 2024

(IMNM) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 13, 2024
pulisher
Nov 13, 2024

Immunome earnings missed by $0.24, revenue topped estimates - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

FMR LLC's Strategic Acquisition of Immunome Inc Shares - GuruFocus.com

Nov 13, 2024
pulisher
Nov 10, 2024

Immunome (NASDAQ:IMNM) Shares Gap Up – Still a Buy? - Defense World

Nov 10, 2024
pulisher
Nov 09, 2024

Stephens & Co. Initiates Coverage of Immunome (IMNM) with Overweight Recommendation - MSN

Nov 09, 2024
pulisher
Nov 08, 2024

Analyst Expectations For Immunome's Future - Benzinga

Nov 08, 2024
pulisher
Nov 08, 2024

Immunome (NASDAQ:IMNM) Shares Gap UpTime to Buy? - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Immunome (NASDAQ:IMNM) Now Covered by Stephens - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Immunome, Inc. (NASDAQ:IMNM) Stake Reduced by Wealth Enhancement Advisory Services LLC - Defense World

Nov 08, 2024
pulisher
Nov 05, 2024

Immunome to Present at Guggenheim’s Inaugural Healthcare Innovation Conference - The Bakersfield Californian

Nov 05, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition of Immunome Inc Shares - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

Immunome (NASDAQ:IMNM) Trading Up 8.7%Time to Buy? - MarketBeat

Nov 04, 2024
pulisher
Nov 02, 2024

Learn to Evaluate (IMNM) using the Charts - Stock Traders Daily

Nov 02, 2024
pulisher
Nov 01, 2024

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan

Nov 01, 2024
pulisher
Nov 01, 2024

Immunome, Inc. (NASDAQ:IMNM) Receives $29.00 Average PT from Brokerages - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Immunome, Inc. (NASDAQ:IMNM) Given Consensus Rating of “Buy” by Analysts - Defense World

Nov 01, 2024
pulisher
Oct 31, 2024

Immunome (NASDAQ: IMNM) Acquires Zentalis Pharmaceuticals’ Licensed Assets IMMUNOME, Inc. made a recent significant move on October 25, 2024, by acquiring Zentalis Pharmaceuticals, Inc.’s Licensed Assets. This acquisition was carried out thr - Defense World

Oct 31, 2024
pulisher
Oct 30, 2024

Immunome Advances with Strategic Asset Acquisition and Agreement - Yahoo Finance

Oct 30, 2024
pulisher
Oct 29, 2024

Immunome Presents Compelling Preclinical Data Demonstrating Robust Anti-Tumor Activity for IM-1021 - Business Wire

Oct 29, 2024
pulisher
Oct 29, 2024

Immunome, Inc. (NASDAQ:IMNM) Short Interest Down 15.2% in October - MarketBeat

Oct 29, 2024
pulisher
Oct 25, 2024

Immunome's (IMNM) Outperform Rating Reiterated at Wedbush - MarketBeat

Oct 25, 2024
pulisher
Oct 18, 2024

Immunome to Present Poster Highlighting Preclinical Evaluation of IM-1021, a ROR1-Targeted Antibody Drug Conjugate, at the 36th EORTC-NCI-AACR Symposium - The Bakersfield Californian

Oct 18, 2024
pulisher
Oct 18, 2024

IMNMImmunome, Inc. Latest Stock News & Market Updates - StockTitan

Oct 18, 2024
pulisher
Oct 15, 2024

Immunome (IMNM) Price Target Increased by 179.17% to 34.17 - MSN

Oct 15, 2024
pulisher
Oct 15, 2024

Cubist Systematic Strategies LLC Reduces Stake in Immunome, Inc. (NASDAQ:IMNM) - Defense World

Oct 15, 2024
pulisher
Oct 15, 2024

Cubist Systematic Strategies LLC Decreases Position in Immunome, Inc. (NASDAQ:IMNM) - MarketBeat

Oct 15, 2024
pulisher
Oct 14, 2024

Understanding the Risks of Investing in Immunome Inc (IMNM) - Knox Daily

Oct 14, 2024
pulisher
Oct 14, 2024

Financial Metrics Exploration: Understanding Immunome Inc (IMNM) Through Ratios - The Dwinnex

Oct 14, 2024
pulisher
Oct 12, 2024

Sei Investments Co. Cuts Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World

Oct 12, 2024
pulisher
Oct 11, 2024

(IMNM) Investment Analysis and Advice - Stock Traders Daily

Oct 11, 2024
pulisher
Oct 10, 2024

Insider Selling: Rosett Max, Immunome Inc [IMNM] Chief Financial Officer divested 14,380 shares - Knox Daily

Oct 10, 2024
pulisher
Oct 10, 2024

Did Immunome Inc (IMNM) perform well in the last session? - US Post News

Oct 10, 2024
pulisher
Oct 10, 2024

The Manufacturers Life Insurance Company Has $2.02 Million Holdings in Immunome, Inc. (NASDAQ:IMNM) - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

Immunome (NASDAQ:IMNM) Shares Down 6.1%Here's Why - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Immunome Inc. launches new inducement plan By Investing.com - Investing.com South Africa

Oct 08, 2024
pulisher
Oct 08, 2024

Immunome names Roee Shahar as EVP, Commercial By Investing.com - Investing.com South Africa

Oct 08, 2024
pulisher
Oct 08, 2024

Immunome (NASDAQ:IMNM) Trading Up 3.5% – Here’s What Happened - Defense World

Oct 08, 2024
pulisher
Oct 08, 2024

Immunome (NASDAQ:IMNM) Trading 3.5% HigherWhat's Next? - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

Immunome Inc. launches new inducement plan - Investing.com

Oct 08, 2024
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
자본화:     |  볼륨(24시간):